Homebiotech

biotech

biotech

Positive data from chronic scrotal content pain trial

Jim Cornall - May 28, 2026

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026

biotech

New data from Parkinson’s disease trial

Jim Cornall - May 27, 2026

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026

AI

Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins

Jim Cornall - August 19, 2025

biotech

Kexing Biopharm partners with IQVIA to expand globally

Jim Cornall - August 18, 2025

biotech

ThinkBio.Ai and UST partner to help biopharma and healthcare

Jim Cornall - August 18, 2025

biotech

ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions

Jim Cornall - August 18, 2025

biotech

Base to Base biotech podcast 22: A new treatment for dry AMD and tackling peanut allergies

Jim Cornall - August 15, 2025

biotech

Trinity Biotech launches preeclampsia testing service

Jim Cornall - August 14, 2025

biotech

First FDA-approved treatment for MacTel

Jim Cornall - August 14, 2025

biotech

Lilly weight loss drug averages 27.3 lbs lost

Jim Cornall - August 14, 2025

1...606162...79 Page 61 of 79

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Positive data from chronic scrotal content pain trial

Jim Cornall - May 28, 2026 0

Sustained Therapeutics, Inc. has presented additional data from its phase 2 study evaluating ST-01, a proprietary non-opioid sustained-release small molecule therapy, in men with...

Thalassaemia treatment gets EU approval

biotech Jim Cornall - May 27, 2026 0

New data from Parkinson’s disease trial

biotech Jim Cornall - May 27, 2026 0

Restoring the “longevity protein”

biotech Jim Cornall - May 27, 2026 0

Positive topline results from phase 2 recurrent ovarian cancer trial

biotech Jim Cornall - May 26, 2026 0